New Pneumococcal Vaccine Shows Promise in Preventing Disease In Adults
Phase I/II data indicate that new investigative pneumococcal conjugate vaccine shows efficacy in preventing disease in adults.
Cancer Drug Prices Continue to Rise
Escalating costs are hitting patients hard. CMS price negotiation and the $2,000 cap on Part D out-of-pocket expenses should benefit many patients with Medicare coverage.
Industry Trends: What to Watch For
From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.
Managing Metabolic Syndrome in Diabetes
Patients with metabolic syndrome and diabetes may be experiencing challenges outside medication management.
Co-Infection of HIV and Monkeypox Is Common
About 40% of people monkeypox also had HIV, according to a CDC study that included almost 2000 monkeypox cases in the United States that occurred during the first 2 months of the outbreak.
Rukobia Works for Some AIDS Patients, According to New Research
ViiV Healthcare reports long-term positive results for its drug, Rukobia (fostemsavir).
How Has the Evolution of Data Changed Independent Pharmacy?
Big data and analytics are everywhere—including in independent pharmacy. But is the collected information being used to help with documentation, care planning, and reimbursement?
Looking at the CAR-T Therapy Landscape
More of these treatments have been approved, but supply chain issues and cost remain obstacles.
Optimizing Outcomes for Pediatric Infusion Therapy
An expert offers considerations and developmentally appropriate interventions to promote high-quality, patient-centered pediatric infusion care.
Patients With HIV More Susceptible to Breakthrough COVID Cases
The risk of breakthrough was higher in people living with HIV regardless of CD4 count or HIV viral suppression, according to findings reported by researchers at Johns Hopkins.
POC Testing Opportunities Are Important Beyond COVID-19
Independent pharmacies can turn this opportunity into a revenue strem